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Abstract (250 words) 
 
Objective 
To assess whether two or more functional somatic symptom complexes (SSCs) 
showed stronger association with psychosocial correlates than single or no SSC after 
adjustment for depression/anxiety and general medical disorders.  
Methods 
In a population-based sample we identified, by standardised questionnaire, 
participants with chronic widespread pain, chronic fatigue and irritable bowel 
syndrome, excluding those with a medical cause for pain/fatigue. We compared 
psychosocial variables in three groups: multiple (>1), single or no FSS, adjusting for 
depression/anxiety and general medical disorders using ordinal logistic regression. 
We evaluated whether multiple SSCs predicted health status 1 year later using 
multiple regression to adjust for confounders. 
Results 
Of 1443 participants (58.0% response) medical records were examined in 990: 4.4% 
(n=44) had 2 or 3 symptom complexes, 16.2% a single symptom complex. Many 
psychosocial adversities were significantly associated with number of SSCs in the 
expected direction but, for many, statistical significance was lost after adjustment 
for depression/anxiety and medical illness. Somatic symptoms, health anxiety,  
impairment and number of prior doctor visits remained significantly associated. 
Impaired health status 1 year later was predicted by multiple somatic symptom 
complexes even after adjustment for depression, anxiety, medical disorders and 
number of   symptoms. 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
Conclusions 
Depression, anxiety, medical illness and health anxiety , demonstrated an exposure-
response relationship with number of somatic symptom complexes. These may be 
core features of all Functional Somatic Syndromes and may explain why number of 
somatic symptom complexes predicted subsequent health status. These features 
merit inclusion in prospective studies to ascertain causal relationships.   
 
Keywords: Chronic Fatigue, Epidemiology, Fibromyalgia, Functional Somatic 
Syndromes, Medically Unexplained Symptoms, Population based.   
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Introduction     
Functional somatic syndromes (FSS), such as chronic fatigue syndrome (CFS), chronic 
widespread pain (fibromyalgia) and irritable bowel syndrome (IBS), are common 
reasons for presenting to medical services but their aetiology is not fully understood. 
The risk factors for these syndromes include: female gender, childhood adversity, 
prior infections, few years of education, low socio-economic status, recent 
threatening life events, anxiety and depressive disorders, health anxiety, 
neuroticism, general medical disorders and numerous somatic symptoms [1-7]. One 
of the most replicated risk markers, however, is the presence of another syndrome, 
i.e. having one FSS is strongly associated with having, or developing, another [3, 8-
11]. In clinical populations between a half and a third of those with a single 
functional somatic syndrome have at least one more; in the general population the 
prevalence of “polysyndromic” functional somatic syndromes has been shown to be 
2- 4%) [9, 12-15].  
 
It is not clear why the occurrence of one functional somatic syndrome predicts the 
development of another, and the risk factors for multiple, as opposed to single, 
functional somatic syndromes have not been extensively investigated. Several 
studies have found that multiple syndromes are associated with a high prevalence of 
depression and anxiety [13,14,16].  On the other hand, studies using latent class 
analysis of particular groups have suggested that patients with multiple FSS form a 
class of their own, separate from that comprised of anxiety and depression [9,17]. 
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Multiple functional somatic syndromes are associated with greater impairment of 
health status than single FSS and with a greater frequency of healthcare use 
[9,14,15,17]. This might reflect the high prevalence of anxiety/depressive or general 
medical disorders, but other associated factors, such as numerous somatic 
symptoms, few years of education and abuse history are known to be associated 
with impairment and high healthcare use [11, 18-21].  
 
The relationship between numerous somatic symptoms and multiple somatic 
syndromes is not clear. To some extent these are overlapping concepts as each FSS 
has its own list of somatic symptoms necessary for the diagnosis so more than one 
FSS is bound to be associated with a greater number of somatic symptoms. This 
appears to be confirmed by studies using cluster or latent class analysis; increasing 
total somatic symptom scores are associated with multiple somatic syndromes [12-
14]. However, latent class analysis of somatic symptoms indicate separate classes for 
multiple FSS and multiple somatic symptoms [9, 17]. One way to study these closely 
associated phenomena is to identify the relationship of each with outcome; there is 
some evidence that chronic fatigue or chronic widespread pain are independent 
predictors of health status, in addition to depression/anxiety and number of somatic 
symptoms [19, 21,22]. We are not aware of any previous prospective study that has 
assessed whether multiple FSS predicts outcome after adjustment for number of 
somatic symptoms, depression/anxiety and general medical disorders. 
 
The current study uses data from a small, population-based study, which we have 
reported previously but we have not previously examined the correlates of multiple 
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syndromes or considered them as a predictor of health status [22, 23]. The study 
allowed us to examine the presence of chronic fatigue, irritable bowel and chronic 
widespread pain, which we refer to as “somatic symptom complexes” as the study 
did not formally assess the presence of these functional somatic syndromes 
according to standardised criteria.  
This study aimed to test the following hypotheses: 
1) That multiple (2 or 3) somatic symptom complexes (SSCs) show a significantly 
higher number of associated features compared to single SSC or no SSC and 
there is an “exposure–response” relationship across the three groups 
(multiple, single and no SSC). 
2) That this difference in associated features between multiple, single and no 
SSCs becomes non-significant after adjustment for depression, anxiety and 
general medical disorders.  
3) That multiple somatic symptom complexes do not form an independent 
predictor of subsequent health status after adjustment for the effect of 
anxiety, depression, general medical illness and bothersome somatic 
symptoms.  
Hypotheses 1 and 2 were tested in a cross-sectional design and hypothesis 3 in a 
prospective design.  
 
Methods 
We conducted a population-based study in which we mailed 2985 baseline 
questionnaires to people aged 25-65 years registered at two general practices in 
North West England, one in an affluent rural area and one in a more deprived inner 
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city area. Potential participants were selected from complete population lists (i.e. GP 
registers) using simple random sampling assuming that the sampled sub-group was 
representative of the population from which they were drawn (Figure 1). The 2490 
who were eligible to participate were sent a questionnaire that assessed the 
presence of chronic widespread pain, chronic fatigue irritable bowel syndrome and a 
number of potential associated factors (see below for details). Non-responders were 
sent a reminder postcard after two weeks and, if necessary, a further questionnaire 
after two further weeks. 
 
Written informed consent was sought to examine participant’s medical records. The 
medical record review identified any general medical illness that could explain the 
presence of pain or fatigue and also allowed us to count the number of consultations 
for the year before and year after questionnaire completion.  
 
Definition of functional somatic symptom complexes  
Chronic widespread pain  (CWP)  
We used the definition of chronic widespread pain included in the American College 
of Rheumatology 1990 criteria for fibromyalgia  (24). Participants were asked to 
report the presence of any musculoskeletal pain they had experienced in the past 
month, whether their pain had persisted for three months or more, and to shade on 
a four-view blank body manikin the location(s) of their pain. Using these data, 
participants were classified as Chronic Widespread Pain if they reported pain, 
present for at least three months: above and below the waist, in the right and left 
hand sides of the body and in the axial skeleton.   
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Chronic fatigue   
The fatigue scale contains 11 items that inquire about symptoms of physical and 
mental fatigue. Individual items are scored 0 or 1, with a total score ranging from 0 
to 11. Participants with fatigue scores of 4 or more on the Fatigue Scale (25) and who 
had reported symptoms for six months or more were classified as having chronic 
fatigue. 
 
Irritable bowel syndrome (IBS) 
We identified those with IBS according to the Rome II criteria [26]. To fulfil these 
criteria participants had to report 3 months of continuous or recurring abdominal 
pain or discomfort and two of the following: (1) relief with a bowel movement, (2) be 
coupled with a change in frequency, or (3) be related to a change in the consistency 
of stools. 
 
Medical record review 
For participants who had agreed, medical records were reviewed for 12 months 
before and after the date of baseline questionnaire by two raters (FC and CCG) to 
see if there was evidence of a recognised medical condition that could explain 
chronic fatigue, irritable bowel syndrome or chronic widespread pain. A conservative 
approach was used; any medical illness that could cause fatigue or widespread pain 
led to exclusion from the relevant functional somatic symptom complex 
classification; only those participants who reported the relevant symptoms but who 
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did not have such a medical illness evident in the GP records were classified as 
having chronic fatigue, chronic widespread pain or irritable bowel.  
 
Socio- demographic details 
These included age, sex, marital status, current work status (including disability 
status), number of years of formal education and details of any outstanding 
compensation claims. 
 
Co-morbid general medical disorders: Respondents were asked if they had any 
common medical disorders on a checklist and to add any not listed. For analysis, 
participants were classified as having none, one, two or more general medical 
disorders. 
 
Symptom experience: The Somatic Symptom Inventory (SSI) asks respondents to rate 
13 bodily symptoms on a 5-point scale as to “how much it has bothered you over the 
past 6 months?” The total score ranges from 13 to 65 with high scores indicating 
greater bother (27). 
The Whitely index is a 14-item measure of health anxiety (28). Each item 
is scored on a 5-point Likert scale, 1 = ‘‘not at all’’ to 5 = ‘‘a great deal.’’ The total 
score ranges from 14 to 70, with high values indicating greater health anxiety. 
 
Childhood Factors 
The Childhood Physical and Sexual Abuse questionnaire consists of 8 questions 
concerning abuse (29). Respondents were rated as having experienced childhood 
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abuse if, before the age of 16 years, they reported that an older person touched 
them or they were made to touch someone else in a sexual way, or intercourse was 
attempted or completed (sexual abuse); that they were hit, kicked or beaten often 
and/or their life was seriously threatened (physical abuse); they were often insulted, 
humiliated or made to feel guilty (psychological abuse). 
 
The Parental Bonding Instrument   includes 7 questions concerning perceived 
maternal care and 1 item concerning maternal control (30,31).  
 
Adult attachment, personality, recent stress and mental state 
The Relationship Scales Questionnaire measures adult attachment style by asking 
respondents to identify which of four sets of characteristics most closely matches 
the way they relate to other people (32). These are: secure (trusting in others), 
preoccupied (emotionally dependent, low self-esteem), fearful (low trust of others, 
fearful of intimacy) and dismissing (low trust in others, compulsively self-reliant). 
 
Social Support was assessed with a question determining whether the respondent 
had a close confidant with whom they can discuss all concerns.  
 
The List of threatening experiences (LTE-Q) measures the experience of 12 
threatening personal situations or events in the last 6 months (33).  The total score 
of positive responses represents recent exposure to threatening experiences; we 
quote the results in 3 groups (0, 1, 2 or more). We also quote separately the scores 
for questions regarding illness in the participant and close relatives. 
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The Revised NEO Personality Inventory (NEO-PI-R) measures the personality trait of 
Neuroticism (34). It has a maximum score of 48 with high scores indicating higher 
levels of neuroticism. 
 
The Hospital Anxiety and Depression Scale (HADS) is a valid and reliable measure of 
anxiety and depression in the general population which avoids questions about 
physical symptoms (e.g. weight loss, pain) that might be caused by general medical 
illness (35) . In this study we quote the anxiety and depression scores. 
Health status and healthcare use 
The Short Form 12 (SF12) Questionnaire assesses health status (36,37). It is a 
validated shortened version of the 36 item version and both versions have been 
used in FSS. The 12 items yield summary scores for mental (SF12-MCS) and physical 
(SF12-PCS) components of health status, which are transformed into norm based 
scoring. A low score represents impairment of health status.  
The Euroqol (EQ5D) asks respondents to rate, problems they experience in mobility, 
self care, usual activities, pain/discomfort and anxiety/depression [38]. It also asks 
respondents to rate, on a vertical “thermometer”, their own health today on a scale 
from 0 (worst imaginable health state) to 100 (best imaginable). It is the latter that 
we used in the prospective part of this study. 
Healthcare use:  For participants who had agreed, medical records were reviewed, 
counting all consultations with the GP or practice nurse for 12 months before and 
after the baseline questionnaire. 
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The study was performed in concordance with the Declaration of Helsinki. It received 
ethical approval from the North Manchester Local Research Ethics Committee (REC 
reference number: 06/Q1406/14). All participants provided written informed 
consent to participate after full explanation of the study.  
 
Statistical analysis 
We divided the participants into 3 groups according to the number of somatic 
symptom complexes: none, one, 2 or 3 (henceforth referred to as “multiple”). These 
3 groups were compared in univariable analysis in terms of the variables listed above 
as potential correlates; socio-demographic, childhood factors, adult attachment, 
recent stress and illness, and mental state measures. Odds ratios and 95% 
confidence intervals for number of symptom complexesare presented for categorical 
measures (table 1), and group means and standard deviations for continuous 
measures (tables 2 and 3).  Ordinal logistic regression was used to test the 
association between categorical baseline variables adjusting for gender, HADS 
anxiety and depression scores, and number of general medical disorders. Continuous 
baseline and 1 year follow up measures in the 3 groups were compared using 
ANOVA.  A multiple regression analysis was used to assess the association between 
number of symptom complexes and each continuous baseline and follow up 
variable, adjusting for gender, HADS anxiety and depression scores, and number of 
general medical disorders.   (tables 2 and 3).  
A multiple regression analysis was used to assess whether number of somatic 
symptom complexes at baseline predicted health status at 1 year follow-up. EQ5D 
“health thermometer” at follow-up was the dependent variable (table 4). The 
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following were entered as independent variables: age, gender, number of general 
medical disorders, somatic symptom score (SSI) , total HADS score (anxiety and 
depression combined) , baseline EQ5D thermometer score and number of somatic 
symptom complexes.  
In the adjusted analyses, inverse probability sampling weights were also used to 
adjust for the non-completion of questionnaires and non-availability of medical 
records and/or 1 year follow up data. For non-completion of baseline questionnaires 
(961 returned out of 1657 eligible), the probability of completion was calculated 
using logistic regression with independent variables, centre, age group and gender. 
For non-availability of medical records and 1 year follow data, the probability of 
obtaining data was calculated using logistic regression with all the baseline variables 
as independent variables.  These probabilities were multiplied together, and their 
reciprocal was used as the sampling weight. All analyses were carried out using Stata 
version 14.  
 
 Results 
Participation rates 
Of the 2490 questionnaires mailed, 1999 (80.3%) were returned, of which 556 
(22.3%) were blank or did not contain usable information (see figure 1). A total of 
1443 (58.0%) participants returned a completed questionnaire and participated in 
the study. Non-responders were significantly more likely to be male (53.1% versus 
42.3%), and younger (mean=43.9 versus 47.0 years) than the remaining eligible 
participants. The participation rates at the two practices were similar (56.3% and 
59.3%). 
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We examined 990 medical records of the 992 participants who gave permission for 
this. Those who refused permission were younger (45.8 v 47.5 years, p = 0.013) and 
more likely to be female (63.2% v 55.5%, p = 0.008) but did not differ in terms of 
marital status, years of education, unemployment, prevalence of somatic symptom 
complex (assessed by questionnaire alone), anxiety, depression or somatic 
symptoms scores. Completed follow up questionnaires were received from 741 (75% 
of the 989 who agreed), of whom 638 (86.1%) also had their medical notes examined 
(figure 1). The 990 participants on whom we had complete baseline data were used 
in the first, cross-sectional part of this study. Data from the 638 participants who 
were followed up were used in the prospective part of the study. 
 
Prevalence of syndromes  
Of the 990 participants, 20 with chronic widespread pain, 9 with IBS and 28 with 
chronic fatigue had pain or fatigue that could be attributed to a co-existing general 
medical illness so these participants were excluded from the relevant somatic 
symptom complexes. After these exclusions 9.4 % (n=93) had Chronic Widespread 
Pain, 3.5 % (n=35) had Irritable Bowel Syndrome and 12.6 % (n=125) had Chronic 
Fatigue. Approximately half of those who reported fatigue, widespread pain or 
abdominal pain had consulted their GP with the relevant symptom and, of these, 
one third had undergone investigations which showed no indication of underlying 
medical illness. Overall, 161 participants (16.3 %) had one syndrome, 40 (4 %) had 
two syndromes and four (0.4 %) reported all three. Figure 2 shows the overlap of 
syndromes.  
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Comparison of somatic symptom complexes  
Many of the features associated with FSS were most frequently recorded in those 
with multiple syndromes and they were distributed in an exposure-response 
relationship across the groups of multiple, single and no somatic symptom groups 
(table 1). After adjustment for gender, anxiety, depression and general medical 
disorders, many of the features were no longer associated with number of symptom 
complexes but  number of somatic symptoms (Somatic Symptom Inventory), health 
anxiety (Whitely index) and number of doctor visits in the previous year remained 
significantly associated. All 3 measures of health status (SF-12 PCS, MCS and EQ5D) 
showed greatest impairment in the multiple FSS group (table 2).   
 
At 1 year follow-up, after adjustment for gender, HADS anxiety and depression and 
number of general medical disorders, the number of somatic symptoms and all 3 
measures of health status showed worst outcome for those with multiple somatic 
symptoms complexes at baseline. The same was true for number of consultations 
during the follow-up year, though this became non-significant after adjustment for 
gender, anxiety, depression, and general medical illness (table 3).  
 
Prediction of health status at 1 year follow-up  
Multiple regression analysis which adjusted for the potential confounders of age, 
gender, number of current medical disorders, Somatic Symptom Inventory (number 
of bothersome somatic symptoms), HADS (anxiety and depression) score and 
baseline EQ5D score demonstrated that number of somatic symptom complexes was 
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an independent predictor of health status at follow-up (table 4).  The significant 
downward trend for none, 1 and multiple somatic symptom complexes at baseline  
(a low score represents impaired health status -table 2)  is maintained at follow up 
(table 3).The mean reductions from baseline to follow up  have been added to table 
3. The positive significant regression coefficient for increase (improvement) in EQ5D 
from baseline to follow up suggest that the improvements are greater for 
participants with more syndromes.  The data for SSI is similar, with negative 
regression coefficient for the change because for SSI a reduced score represents 
improvement. 
All the analyses combining these with the participants who had 2 symptom 
complexes have been repeated with these 4 participants in a separate higher group. 
The results are very similar to those presented and do not alter any conclusions. 
Therefore we conclude that this extra category has only a negligible influence on the 
results. For example in table 4, the regression coefficient for symptom complexes in 
4 groups (0 vs 1 vs 2 vs 3 on an ordinal scale) is -3.58, 95% CI -6.79 to -0.37, p=0.029.  
Discussion 
Our first hypothesis was upheld, the presence of multiple somatic symptom 
complexes was associated with a wide range of the usually accepted risk factors for 
these disorders and there was an “exposure–response” relationship across the three 
groups: none, one and multiple functional somatic symptom complexes. Many of 
these associations became non-significant when we adjusted for depression, anxiety 
and general medical illness, confirming, in part, our second hypothesis, but  the 
scores for bothersome somatic symptoms, health anxiety, impairment of health 
status and number of prior doctor visits remained significantly  associated with more   
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symptom complexes . Our third hypothesis was not upheld; multiple somatic 
symptom complexes formed an independent risk factor for poor outcome after 
adjustment for the effect of anxiety, depression general medical illness and 
bothersome somatic symptoms. 
 
Before discussing these results further it is important to note a number of limitations 
of this study. This was a questionnaire-based study which meant we were not able to 
establish the diagnosis of the 3 functional somatic syndromes according to 
standardised criteria. We used the questionnaire-based syndrome definitions of 
irritable bowel syndrome and chronic widespread pain which have been used widely 
in population-based studies, but we measured chronic fatigue, rather than chronic 
fatigue syndrome. We did, however, examine participants’ medical notes and 
excluded from our functional somatic symptom groups those who had a medical 
illness that might explain the fatigue, pain or disturbed bowel function. This is a 
strength of this study compared to many other population-based ones. Another 
major strength of the study was the statistical analysis which, unlike many others, 
adjusted for the well-recognised associated features of anxiety, depression and 
general medical disorders, revealing, for the first time, further independent 
associated features.  
 
Another major limitation is the cross-sectional design of the associated features part 
of the study. This needs to be replicated in a prospective design to establish whether 
the associated features we have identified predict subsequent syndrome 
development rather than being a consequence of the syndrome. The small number 
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of respondents and the relatively low response rate are also limitations though we 
were able to show a) how the responders and non-responders differed and b) that, 
among those who did and did not agree to a medical record review, there were no 
major differences on many of the key variables. We also adjusted for possible bias 
between our sample and the population of eligible participants using inverse 
probability weighting in our analyses. 
 
The prevalence of the 3 somatic symptom complexes in this study is comparable 
with other studies using similar criteria (13, 39,40). The threshold for inclusion in the 
somatic symptom complex groups might be considered to be rather low (e.g. we 
measured chronic fatigue not chronic fatigue syndrome) but these criteria did yield 
satisfactory numbers for statistical analysis and the prevalence of 2 or more somatic 
symptoms complexes (4.4%) is not far outside the range of previous studies (9,12-
15). The group with multiple somatic symptom complexes had greater impairment of 
health status than those with a single or no functional somatic syndromes and this 
difference remained at one year follow-up (table 3). The magnitude of the 
differences on EQ5D thermometer at baseline and at follow-up were quite marked in 
line with other studies (9,14,15,17).   In addition, the multiple somatic symptom 
group attended primary care more frequently both before and during the year after 
our first assessment. These findings suggest validity of the somatic symptom 
complex groups we identified. Furthermore, we found that most of the purported 
risk factors for the functional somatic syndromes were associated with one or more 
somatic symptom complexes in our cross-sectional analysis. The main exception is 
the lack of a predominance of females; the reason for this is not clear.   
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The associated features of the somatic symptom complexes in this study show 
differences in the expected direction,  with a higher incidence of risk factors being 
associated with more symptom complexes. The unadjusted odds ratios were quite 
marked (column 4 in table 1). Although we have confirmed that anxiety, depression 
and comorbid physical conditions are associated with multiple somatic symptom 
complexes, there are others, namely:  somatic symptoms and health anxiety. This 
confirms the notion that those people who have more than one somatic symptom 
complex have a greater load of “risk factors” than those with one or no such 
complex, at least in a cross-sectional analysis.  
 
Much previous research concerning multiple functional somatic syndromes has used 
latent class analysis to define groups of participants. Three studies, both population-
based and clinical, found separate groups for multiple functional somatic syndromes 
and for anxiety/depression; one study also found an additional group with numerous 
somatic symptoms (9,14, 17). This, together with our analysis showing the predictors 
of health status, suggests that the dimensions of a) multiple somatic syndromes, b) 
numerous somatic symptoms and c) anxiety/depression need to be considered as 
separated dimensions in future research. It has been previously assumed that 
numerous somatic symptoms is synonymous with anxiety and depression, and we 
have shown this is not the case.   
There has been less work concerning the associated features of multiple functional 
somatic syndromes. A preponderance of females in this group was reported by one 
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other study but contradicted by another (9,15). General medical disorders, a feature 
neglected in some studies, is another feature (5,6,9,11, 41) as are health anxiety and 
frequent consultation (14). Numerous other somatic symptoms or syndromes, mood 
disorder, health anxiety, neuroticism, adverse life events, impaired quality of life and 
increased health care seeking emerged from a study of patients with irritable bowel 
syndrome and another somatic syndrome (42 ). This list is similar to our findings. It is 
also similar to the features reported to be common to several individual functional 
somatic syndromes; female gender, high health anxiety, other somatic symptoms,  
childhood psychological abuse and recent adverse life events (10, 23). Thus there 
seems to be a growing consensus of the risk factors which may be regarded as the 
“core features” or predisposing factors that are encapsulated in the “lumpers” 
argument that all functional somatic syndromes are manifestations of the same 
underlying disorder (43). They are common to all FSS and a greater number of these 
features is associated with multiple FSS.  
The main implication of this study involves further research. Firstly, we need to know 
whether these correlates are true risk factors associated with the development of 
new syndromes and, secondly, we need to understand whether a high “risk load” 
predicts the development of multiple syndromes. Alternatively, or, in addition, they 
may predict persistence of somatic symptoms which could contribute to the 
development of multiple syndromes. Answering these questions would need large 
prospective studies. Further research is needed to assess whether our findings hold 
in functional somatic syndromes other than Irritable Bowel Syndrome, Chronic 
Fatigue syndrome and Chronic widespread pain.  
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From the clinical perspective, patients with multiple functional somatic syndromes 
should be assessed for all of these associated features, as this may help guide the 
clinician in management decisions as well as being helpful in predicting outcome 
(44).  
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Figure 1 Flow of study participants 
Figure 2 Co-occurrence of functional somatic symptom complexes. 
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Table 1 Baseline categorical measures according to confirmed medically unexplained 
syndrome groupings (n=990). 
Baseline measures 
 
No 
syndro
mes 
n=785 
No (%) 
One 
syndro
me 
n=161 
No (%) 
2 or 3 
syndro
mes  
n=44  
No (%) 
 
Od
ds 
rati
o a 
 
95% 
confide
nce 
interval 
a 
 
Od
ds 
rati
o b 
 
95% 
confide
nce 
interval 
b 
Female 426 
(54.3%) 
96 
(59.6%) 
27 
(61.4%) 
1.2
5 
0.93 to 
1.73 
- - 
Single 
Married (reference 
category) 
Separated/widowed/
divorced 
118 
(15.1%) 
597 
(76.4%) 
66 
(8.5%) 
26 
(16.5%) 
110 
(69.6%) 
22 
(13.9%) 
4 (9.3%) 
25 
(58.1%) 
14 
(32.6%) 
0.9
6 
1.0 
2.5
7 
0.62 to 
1.48 
- 
1.66 to 
3.99 
0.7
6 
1.0 
1.5
2 
0.48 to 
1.22 
- 
0.91 to 
2.54 
More than 12 years of 
education  
573 
(74.8%) 
108 
(68.8%) 
24 
(55.8%) 
0.6
4 
0.46 to 
0.89 
0.7
7 
0.53 to 
1.14 
No confidant  42 
(5.4%) 
16 
(9.9%) 
6 
(13.6%) 
2.1
5 
1.26 to 
3.66 
1.0
6 
0.51 to 
2.21 
Working (reference 
category) 
Unemployed 
(seeking work) 
Not working (ill 
health) 
Student, retired, etc 
622 
(80.6%) 
12 
(1.6%) 
15 
(1.9%) 
123 
(15.9%) 
128 
(80.5%) 
4 
(2.5%) 
3 
(1.9%) 
24 
(15.1%) 
28 
(65.1%) 
2 (4.7%) 
8 
(18.6%) 
5 
(11.6%) 
1.0 
2.0
3 
1.9
4 
0.8
8 
- 
0.76 to 
5.43 
1.25 to 
3.00 
0.57 to 
1.35 
1.0 
1.3
4 
1.0
3 
0.9
8 
- 
0.36 to 
5.00 
0.61 to 
1.74 
0.60 to 
1.59 
Off work due to ill 
health in the past 
month 
77 
(10.2%) 
23 
(14.6%) 
11 
(27.5%) 
4.2
5 
1.87 to 
9.66 
1.0
2 
0.41 to 
2.55 
Compensation claim 6 (0.8%) 2 
(1.3%) 
2 (4.5%) 3.0
3 
0.85 to 
10.8 
2.0
7 
0.44 to 
9.73 
Current illness 2 or 
more (n=642) 
54 
(10.4%) 
24 
(23.8%) 
10 
(31.3%) 
2.9
2 
1.82 to 
4.68 
2.3
5 c 
1.42 to 
3.89 c 
Childhood factors:        
Any childhood abuse 47 
(6.0%) 
9 
(5.6%) 
9 
(20.5%) 
1.6
9 
0.95 to 
2.98 
0.9
5 
0.49 to 
1.83 
Sexual abuse 81 
(10.4%) 
24 
(14.9%) 
8 
(18.2%) 
1.6
1 
1.04 to 
2.50 
1.1
5 
0.70 to 
1.89 
Psychological abuse   35 
(4.5%) 
8 
(5.0%) 
8 
(18.2%) 
2.0
7 
1.12 to 
3.83 
0.9
5 
0.46 to 
1.95 
Physical abuse  25 
(3.2%) 
5 
(3.1%) 
5 
(11.4%) 
1.7
4 
0.82 to 
3.70 
1.0
4 
0.41 to 
2.64 
Loss of mother 
<16yrs 
13 
(1.7%) 
6 
(3.7%) 
3 (6.8%) 2.8
5 
1.22 to 
6.66 
2.1
4 
0.97 to 
4.74 
Loss of father <16yrs 40 
(5.1%) 
9 
(5.6%) 
3 (6.8%) 1.1
7 
0.60 to 
2.26 
1.0
1 
0.44 to 
2.32 
Recent stress        
Recent serious 
illness or injury 
(participant)  
41 
(5.2%) 
12 
(7.5%) 
12 
(27.3%) 
2.8
1 
1.65 to 
4.77 
0.9
3  
0.46 to 
1.87  
Recent serious 
illness or injury (close 
relative) 
162 
(21.0%) 
50 
(31.3%) 
14 
(31.8%) 
1.7
1 
1.22 to 
2.41 
1.3
6 
0.93 to 
1.99 
Death of close 
relative 
35 
(4.5%) 
11 
(6.8%) 
5 
(11.4%) 
1.8
7 
1.02 to 
3.44 
1.4
6 
0.68 to 
3.12 
Death of close friend 118 
(15.1%) 
25 
(15.5%) 
15 
(34.1%) 
1.4
5 
0.97 to 
2.15 
1.0
6 
0.67 to 
1.69 
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Odds ratio and 95% confidence interval calculated using ordinal regression for syndromes in 3 groups: 0 
vs 1 vs 2 or 3  
a unadjusted 
b weighted for sampling and adjusted for gender, HADS anxiety and depression, and number of general 
medical illnesses. 
c weighted for sampling and adjusted for gender, and HADS anxiety and depression. 
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Table 2 Scored measures at baseline according to confirmed medically unexplained syndrome groupings 
(n=990). 
 
 
 
Baseline 
Scores  
No 
syndrome
s 
n=785 
mean (sd) 
a 
One 
syndrom
e n=161 
mean 
(sd) a 
2 or 3 
syndrome
s  
n=44  
mean (sd) 
a 
 
F a  
2,98
7 df  
 
 
sig a 
 
 
B b 
 
 
95%
CI for 
B b 
 
 
sig b 
Age  47.5 
(11.4) 
46.8 
(11.8) 
48.7 
(10.5) 
0.5 0.59 0.0
5 
-1.34 
to 
1.44 
0.95 
Maternal 
care score 
16.5 (4.9) 16.1 (5.3) 14.6 (6.2) 3.0 0.048 0.2
0 
-0.48 
to 
0.88 
0.56 
Maternal 
control 
score  
0.89 
(1.02) 
0.97 
(1.01) 
1.17 
(1.24) 
1.8 0.17 -
0.0
1 
-0.16 
to 
0.13 
0.87 
Neuroticism 
score 
16.0 (8.6) 21.7 (9.5) 26.7 (9.3) 54.2 <0.00
1 
0.6
7 
-0.19 
to 
1.53 
0.13 
HADS 
anxiety c 
5.5 (3.5) 7.6 (4.0) 10.8 (4.5) 59.9 <0.00
1 
2.3
4 
1.85 
to 
2.84 
<0.00
1 
HADS 
depression c 
2.5 (2.6) 4.6 (3.5) 7.5 (4.1) 89.5 <0.00
1 
2.1
3 
1.72 
to 
2.55 
<0.00
1 
Whitely 
Index 
21.0 (6.6) 25.8 (9.0) 31.8 
(11.9) 
48.2 <0.00
1 
1.9
7 
0.79 
to 
3.15 
0.001 
Secure 
attachment 
4.6 (1.6) 4.3 (1.7) 3.7 (1.8) 6.9 0.001 -
0.0
1 
-0.22 
to 
0.21 
0.96 
Fearful 
attachment 
2.5 (1.6) 2.8 (1.8) 3.7 (2.1) 12.9 <0.00
1 
-
0.0
5 
-0.29 
to 
0.19 
0.70 
Somatic 
symptom 
inventory 
score 
19.9 (5.4) 24.7 (6.1) 33.6 (9.3) 153.
0 
<0.00
1 
3.2
9 
2.48 
to 
4.09 
<0.00
1 
Threatening 
experiences 
score (all 
12 items) 
0.82 
(1.14) 
1.24 
(1.41) 
2.07 
(2.10) 
26.4 <0.00
1 
0.1
7 
-0.01 
to 
0.35 
0.060 
Threatening 
experiences 
score 
(excluding 
illness of 
subject) 
0.77 
(1.10) 
1.17 
(1.35) 
1.80 
(1.86) 
21.4 <0.00
1 
0.1
6 
-0.01 
to 
0.33 
0.061 
SF-12 
physical 
score 
51.5 (8.5) 48.4 (9.1) 39.8 
(11.0) 
43.4 <0.00
1 
-
2.3
1 
-3.57 
to -
1.04 
<0.00
1 
SF-12 
mental 
score 
49.8 (9.2) 42.7 
(12.3) 
34.4 
(10.8) 
77.4 <0.00
1 
-
2.0
0 
-3.05 
to -
0.94 
<0.00
1 
EQ5D 
Thermomet
er 
81.8 
(14.0) 
74.7 
(16.6) 
58.6 
(21.9) 
60.6 <0.00
1 
-
2.0
2 
-3.84 
to -
0.20 
0.030 
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No of 
consultation
s in primary 
care in the 
previous 
year 
1.8 (2.2) 2.6 (2.6) 3.7 (3.5) 17.7 <0.00
1 
0.4
1 
0.06 
to 
0.77 
0.023 
 
a unadjusted means, standard deviations and comparison using ANOVA 
b unstandardised regression coefficient B and 95% confidence interval for the independent 
variable 3 syndrome groups and with each baseline score as dependent variable. Analyses 
weighted for sampling and adjusted for gender, HADS anxiety and depression, and number of 
illnesses  
c as for b above weighted for sampling, but adjusted for gender and number of illnesses only. 
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Table 3 Scored measures at follow up by number of medically unexplained syndrome grouping at 
baseline. 
 
 
Outcome 
measures 
at 1 year 
(n=638) 
No 
syndrome
s 
n=500 
mean (sd) 
a 
One 
syndrom
e n=108 
mean 
(sd) a 
2 or 3 
syndrome
s  
n=30 
mean (sd) 
a 
 
F a  
2,63
6 df 
 
 
sig a 
 
 
B b 
 
 
 
95%
CI for 
B b 
 
 
sig b 
Somatic 
symptom 
inventory 
score 
19.7 (5.3) 23.3 (6.3) 32.7 (9.0) 86.6 <0.00
1 
3.0
2 
2.02 
to 
4.02 
<0.00
1 
SF12 
physical 
score 
51.0 (8.8) 48.6 (9.0) 39.2 
(11.9) 
26.1 <0.00
1 
-
2.0
8 
-3.68 
to -
0.48 
<0.00
1 
SF12 
mental 
score 
50.3 (9.9) 45.3 
(12.2) 
37.9 (9.9) 28.1 <0.00
1 
-
1.1
4 
-2.86 
to 
0.57 
0.19 
EQ5D 
Thermomet
er 
82.3 
(14.8) 
74.8 
(17.1) 
54.3 
(24.5) 
49.7 <0.00
1 
-
4.6
6 
-7.79 
to -
1.53 
0.004 
HADS 
anxiety c 
5.1 (3.6) 6.9 (4.4) 9.3 (4.4) 25.2 <0.00
1 
2.0
1 
1.29 
to 
2.72 
<0.00
1 
HADS 
depression c 
2.5 (3.0) 3.8 (3.6) 6.9 (4.4) 31.7 <0.00
1 
1.6
2 
1.01 
to 
2.22 
<0.00
1 
No. 
consultation
s in primary 
care in the 
year 
following 
initial 
interview 
2.0 (2.2) 2.6 (2.7) 3.7 (3.8) 12.0 <0.00
1 
0.1
7 
-0.19 
to 
0.53 
0.36 
         
Change in 
outcome 
measure 
(follow up 
score – 
baseline 
score) 
No 
syndrome
s 
n=500 
mean (sd) 
a 
One 
syndrom
e n=108 
mean 
(sd) a 
2 or 3 
syndrome
s  
n=30 
mean (sd) 
a 
 
F a  
2,63
6 df 
 
 
sig a 
 
 
B d 
 
 
 
95%
CI for 
B d 
 
 
sig d 
Somatic 
symptom 
inventory 
score 
0.12 
(4.35) 
0.90 
(5.06) 
1.20(5.09) 1.9 0.15 -
0.9
6 
-1.87 
to -
0.05 
0.039 
EQ5D 
Thermomet
er 
-0.09 
(13.9) 
0.93 
(15.2) 
6.24 
(20.2) 
2.7 0.068 3.7
6 
0.73 
to 
6.80 
0.015 
 
a unadjusted means, standard deviations and comparison using ANOVA 
b unstandardised regression coefficient B and 95% confidence interval for the independent 
variable 3 syndrome groups and with each baseline score as dependent variable. Analyses 
weighted for sampling and adjusted for gender, HADS anxiety and depression, and number of 
illnesses  
c as for b above weighted for sampling, but adjusted for gender and number of illnesses only 
d as for b above weighted for sampling, but adjusted for baseline score in addition to gender, 
HADS anxiety and depression and number of illnesses  
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Table 4 Results of multiple regression analysis with EQ5D thermometer at follow up as 
dependent variable (n=629).    
 
Baseline variables B 
 
95%CI for B  
 
sig  
Age  -0.074 -0.17 0.13 
Female gender 0.994 -1.29 to 3.28 0.39 
Number  of general medical 
illnesses 
0.189 
 
-1.88 to 2.26 .0.86 
SSI  -0.123 -0.44 to 1.20 0.45 
Total HADS  -0.470 -0.77 to -0.17 0.002 
EQ5D thermometer  0.470 0.35 to 0.59 <0.001 
Number of somatic symptom 
complexes (in 3 groups 0 vs 1 vs 
2 or 3) 
 
-3.52 
 
-6.89 to -0.16 
 
0.040 
 
B = unstandardised regression coefficient.  
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Highlights 
 
What's already known about this topic? 
 An existing  functional somatic syndrome is a risk factor for developing 
another.  
 Multiple functional somatic syndromes are associated with anxiety, 
depression and general medical disorders but also with distress, impaired 
function and high healthcare use. 
 
What does this study add? 
 Somatic symptoms, health anxiety, impairment and number of prior doctor 
visits are  associated features that show an exposure-response relationship 
with number of functional somatic symptom complexes even after 
adjustment for depression, anxiety and general medical disorders. 
 Impaired health status 1 year later was predicted by multiple somatic 
symptom complexes even after adjustment for depression, anxiety, medical 
disorders and number of somatic symptoms. 
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